Apotex IPO Filing Lifts Toronto Exchange as Canadian Drugmaker Goes Public
Apotex's Toronto IPO filing advances the Canadian drugmaker's public listing, potentially boosting the TSX and healthcare sector sentiment.
Apotex's Toronto IPO filing advances the Canadian drugmaker's public listing, potentially boosting the TSX and healthcare sector sentiment.
Astellas Pharma shares fell in Tokyo after the company’s five-year strategic plan disappointed investors with modest growth targets and pipeline uncertainty.
Denmark's GDP outlook upgrade driven by pharmaceutical exports underscores the economic influence of Novo Nordisk's Ozempic and Wegovy, lifting growth expectations and…